skip to main content
Idioma:

GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients

Carlson, Jay W. ; Kauderer, James ; Hutson, Alan ; Carter, Jeanne ; Armer, Jane ; Lockwood, Suzy ; Nolte, Susan ; Stewart, Bob R. ; Wenzel, Lari ; Walker, Joan ; Fleury, Aimee ; Bonebrake, Albert ; Soper, John ; Mathews, Cara ; Zivanovic, Oliver ; Richards, Wm Edward ; Tan, Annie ; Alberts, David S. ; Barakat, Richard R.

Gynecologic oncology, 2020-02, Vol.156 (2), p.467-474 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
  • Título:
    GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients
  • Autor: Carlson, Jay W. ; Kauderer, James ; Hutson, Alan ; Carter, Jeanne ; Armer, Jane ; Lockwood, Suzy ; Nolte, Susan ; Stewart, Bob R. ; Wenzel, Lari ; Walker, Joan ; Fleury, Aimee ; Bonebrake, Albert ; Soper, John ; Mathews, Cara ; Zivanovic, Oliver ; Richards, Wm Edward ; Tan, Annie ; Alberts, David S. ; Barakat, Richard R.
  • Assuntos: Adult ; Aged ; Aged, 80 and over ; Cervical cancer ; Endometrial cancer ; Female ; Genital Neoplasms, Female - diagnosis ; Genital Neoplasms, Female - epidemiology ; Genital Neoplasms, Female - surgery ; Humans ; Incidence ; Leg - pathology ; Lymph Node Excision - adverse effects ; Lymph Node Excision - statistics & numerical data ; Lymphadenectomy ; Lymphedema ; Lymphedema - epidemiology ; Lymphedema - etiology ; Lymphedema - pathology ; Middle Aged ; Prospective Studies ; Regression Analysis ; Risk Factors ; Staging ; Vulvar cancer
  • É parte de: Gynecologic oncology, 2020-02, Vol.156 (2), p.467-474
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
    AUTHOR CONTRIBUTIONS Study concept and design: Jay W. Carlson, James Kauderer, Alan Hutson, Jeanne Carter, Jane Armer, Suzy Lockwood, Susan Nolte, Bob Stewart, Lari Wenzel, Dave Alberts, Richard R. BarakatProvision of materials or patients: Jay W. Carlson, Joan Walker, Aimee Fleury, Albert Bonebrake, John Soper, Cara Mathews, Oliver Zivanovic, William Richards, Anne Tan, Richard R. BarakatAcquisition of data: Jay W. Carlson, James Kauderer, Richard R. BarakatAnalysis and interpretation of data: Jay W. Carlson, James Kauderer, Alan Hutson, Jeanne CarterManuscript writing: Jay W. Carlson, James Kauderer, Alan Hutson, Jeanne Carter, Richard R. BarakatCritical review of the manuscript: Jay W. Carlson, James Kauderer, Alan Hutson, Jeanne Carter, Jane Armer, Suzy Lockwood, Susan Nolte, Bob Stewart, Lari Wenzel, Joan Walker, Aimee Fleury, Albert Bonebrake, John Soper, Cara Mathews, Oliver Zivanovic, William Richards, Anne Tan, Dave Alberts, Richard R. BarakatFinal approval of manuscript: Jay W. Carlson
  • Descrição: To evaluate the incidence and risk factors for lymphedema associated with surgery for gynecologic malignancies on GOG study 244. Women undergoing a lymph node dissection for endometrial, cervical, or vulvar cancer were eligible for enrollment. Leg volume was calculated from measurements at 10-cm intervals starting 10 cm above the bottom of the heel to the inguinal crease. Measurements were obtained preoperatively and postoperatively at 4–6 weeks, and at 3-, 6-, 9-, 12-, 18-, and 24- months. Lymphedema was defined as a limb volume change (LVC) ≥10% from baseline and categorized as mild: 10–19% LVC; moderate: 20–40% LVC; or severe: >40% LVC. Risk factors associated with lymphedema were also analyzed. Of 1054 women enrolled on study, 140 were inevaluable due to inadequate measurements or eligibility criteria. This left 734 endometrial, 138 cervical, and 42 vulvar patients evaluable for LVC assessment. Median age was 61 years (range, 28–91) in the endometrial, 44 years (range, 25–83) in the cervical, and 58 years (range, 35–88) in the vulvar group. The incidence of LVC ≥10% was 34% (n = 247), 35% (n = 48), and 43% (n = 18), respectively. The peak incidence of lymphedema was at the 4–6 week assessment. Logistic regression analysis showed a decreased risk with advanced age (p = 0.0467). An exploratory analysis in the endometrial cohort showed an increased risk with a node count >8 (p = 0.033). For a gynecologic cancer, LVC decreased with age greater than 65, but increased with a lymph node count greater than 8 in the endometrial cohort. There was no association with radiation or other risk factors. •Lymphedema as defined by volume change ≥10% was found in 34% of endometrial, 35% of cervical, and 43% of vulvar patients.•Regression analysis showed risk decreased with advanced age (p = 0.0467) and increased with a node count >8 (p = 0.033).•Increase risk of lymphedema was not associated with radiation, advanced stage or other commonly reported risk factors.•Final conclusions were weakened by 50% lost to follow-up and discrepancies in measurements identified in 32% of patients.
  • Editor: United States: Elsevier Inc
  • Idioma: Inglês
Links
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  2 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.